Skip Navigation


Human Molecular Genetics Advance Access originally published online on September 19, 2007
Human Molecular Genetics 2007 16(24):3008-3016; doi:10.1093/hmg/ddm259
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
16/24/3008    most recent
ddm259v2
ddm259v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Dideberg, V.
Right arrow Articles by Syvänen, A.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dideberg, V.
Right arrow Articles by Syvänen, A.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

Vinciane Dideberg1,6, Gudlaug Kristjansdottir6, Lili Milani6, Cécile Libioulle3, Snaevar Sigurdsson6, Edouard Louis2, Ann-Christin Wiman6, Séverine Vermeire4, Paul Rutgeerts4, Jacques Belaiche2, Denis Franchimont5, André Van Gossum5, Vincent Bours1 and Ann-Christine Syvänen6,*

1 Department of Human Genetics, CHU de Liège, 2 Department of Hepatology and Gastroenterology, CHU de Liège and 3 Factorial and Molecular Genetics, GIGA-R, University of Liège, Liège, Belgium, 4 Department of Gastroenterology, UZ Gasthuisberg, Leuven, Belgium, 5 Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium and 6 Molecular Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden

* To whom correspondence should be addressed at: Department of Medical Sciences, Uppsala University, Academic Hospital, Entrance 70, Third Floor, Research Department 2, 75185 Uppsala, Sweden. Tel: +46 186112959; Fax: +46 18553601; Email: ann-christine.syvanen{at}medsci.uu.se

Received August 9, 2007; Accepted September 4, 2007

The interferon regulatory factor 5 (IRF5) gene encodes a transcription factor that plays an important role in the innate as well as in the cell-mediated immune responses. The IRF5 gene has been shown to be associated with systemic lupus erythematosus and rheumatoid arthritis. We studied whether the IRF5 gene is also associated with inflammatory bowel diseases (IBD), Crohn disease (CD) and ulcerative colitis (UC). Twelve polymorphisms in the IRF5 gene were genotyped in a cohort of 1007 IBD patients (748 CD and 254 UC) and 241 controls from Wallonia, Belgium. The same polymorphisms were genotyped in a confirmatory cohort of 311 controls and 687 IBD patients (488 CD and 192 UC) from Leuven, Belgium. A strong signal of association [P=1.9x10–5, odds ratio (OR) 1.81 (1.37–2.39)] with IBD was observed for a 5 bp indel (CGGGG) polymorphism in the promoter region of the IRF5 gene. The association was detectable also in CD patients (P=6.8x10–4) and was particularly strong among the UC patients [P=5.3x10–8, OR=2.42 (1.76–3.34)]. The association of the CGGGG indel was confirmed in the second cohort [P=3.2x10–5, OR=1.59 (1.28–1.98)]. The insertion of one CGGGG unit is predicted to create an additional binding site for the transcription factor SP1. Using an electrophoretic mobility shift assay, we show allele-specific differences in protein binding to this repetitive DNA-stretch, which suggest a potential function role for the CGGGG indel.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
S. Sigurdsson, G. Nordmark, S. Garnier, E. Grundberg, T. Kwan, O. Nilsson, M.-L. Eloranta, I. Gunnarsson, E. Svenungsson, G. Sturfelt, et al.
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Hum. Mol. Genet., September 15, 2008; 17(18): 2868 - 2876.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
G Kristjansdottir, J K Sandling, A Bonetti, I M Roos, L Milani, C Wang, S M Gustafsdottir, S Sigurdsson, A Lundmark, P J Tienari, et al.
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
J. Med. Genet., June 1, 2008; 45(6): 362 - 369.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Paun, J. T. Reinert, Z. Jiang, C. Medin, M. Y. Balkhi, K. A. Fitzgerald, and P. M. Pitha
Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response
J. Biol. Chem., May 23, 2008; 283(21): 14295 - 14308.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Sigurdsson, H. H.H. Goring, G. Kristjansdottir, L. Milani, G. Nordmark, J. K. Sandling, M.-L. Eloranta, D. Feng, N. Sangster-Guity, I. Gunnarsson, et al.
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus
Hum. Mol. Genet., March 15, 2008; 17(6): 872 - 881.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.